HCP, Inc. (NYSE:HCP) – Equities researchers at Capital One Financial increased their Q1 2019 earnings estimates for HCP in a research report issued to clients and investors on Tuesday, March 12th. Capital One Financial analyst D. Bernstein now expects that the real estate investment trust will post earnings per share of $0.43 for the quarter, up from their previous estimate of $0.42. Capital One Financial also issued estimates for HCP’s Q2 2019 earnings at $0.42 EPS, Q3 2019 earnings at $0.42 EPS, FY2019 earnings at $1.70 EPS, Q1 2020 earnings at $0.44 EPS, Q2 2020 earnings at $0.45 EPS, Q3 2020 earnings at $0.44 EPS, Q4 2020 earnings at $0.44 EPS and FY2020 earnings at $1.77 EPS.
Get HCP alerts:HCP (NYSE:HCP) last posted its quarterly earnings data on Wednesday, February 13th. The real estate investment trust reported $1.73 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.43 by $1.30. HCP had a return on equity of 18.40% and a net margin of 57.41%. The company had revenue of $441.92 million during the quarter, compared to analysts’ expectations of $445.81 million. During the same quarter in the previous year, the business earned $0.48 EPS. HCP’s revenue was down .3% compared to the same quarter last year.
HCP has been the subject of several other reports. Zacks Investment Research upgraded HCP from a “sell” rating to a “hold” rating in a report on Thursday. TheStreet upgraded HCP from a “c” rating to a “b-” rating in a report on Wednesday, February 13th. BMO Capital Markets reiterated a “buy” rating and issued a $33.00 target price on shares of HCP in a report on Wednesday, February 13th. Scotiabank started coverage on HCP in a report on Monday, December 10th. They issued an “outperform” rating and a $32.00 target price for the company. Finally, Robert W. Baird upgraded HCP from a “neutral” rating to an “outperform” rating in a report on Monday, January 7th. One analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $28.14.
HCP opened at $31.30 on Thursday. HCP has a 52-week low of $21.80 and a 52-week high of $31.88. The company has a debt-to-equity ratio of 0.85, a current ratio of 0.64 and a quick ratio of 0.64. The firm has a market cap of $14.86 billion, a P/E ratio of 17.20, a price-to-earnings-growth ratio of 7.75 and a beta of 0.46.
The company also recently announced a quarterly dividend, which was paid on Thursday, February 28th. Shareholders of record on Tuesday, February 19th were issued a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 4.73%. The ex-dividend date was Friday, February 15th. HCP’s dividend payout ratio is 81.32%.
Hedge funds and other institutional investors have recently modified their holdings of the stock. American Century Companies Inc. increased its position in HCP by 1.4% during the 4th quarter. American Century Companies Inc. now owns 2,364,632 shares of the real estate investment trust’s stock valued at $66,044,000 after buying an additional 32,826 shares in the last quarter. Norges Bank acquired a new position in HCP during the 4th quarter valued at about $128,473,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in HCP during the 4th quarter valued at about $264,000. Nordea Investment Management AB increased its position in HCP by 4.7% during the 4th quarter. Nordea Investment Management AB now owns 23,710 shares of the real estate investment trust’s stock valued at $663,000 after buying an additional 1,054 shares in the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC increased its position in HCP by 73.8% during the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,036,864 shares of the real estate investment trust’s stock valued at $392,050,000 after buying an additional 5,960,734 shares in the last quarter. Hedge funds and other institutional investors own 94.74% of the company’s stock.
HCP Company Profile
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Read More: Mutual Funds
No comments:
Post a Comment